SER Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Serina Therapeutics Inc (SER) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak technical indicators, insider selling, no positive news catalysts, and poor financial performance. Given the lack of positive signals, it is better to avoid this stock at the moment.
The technical indicators are bearish. The MACD is negative and expanding downward (-0.0156), the RSI is neutral at 39.027, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with a pre-market price of 1.91 below S1 (1.877).
NULL identified. No recent news or positive developments.
Insiders are selling heavily, with a 489.78% increase in selling over the last month. The stock has a 40% chance of declining by -2.96% in the next day and -12.02% in the next month.
The company's financial performance is weak. In Q4 2025, revenue remains at 0 with no growth, net income is negative at -$3,336,000 (up 21.75% YoY), and EPS is negative at -0.31 (up 3.33% YoY). While there is some improvement in net income and EPS, the overall financials remain poor.
No analyst rating or price target data available.
